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CD4 and CD8 areaccessorymolecules expressedon distinct subsets ofperipheral
T lymphocytes that recognize antigens in association with class II and class I MHC
molecules, respectively. Although peripheral T cell pool contains only single-positive
(SP) CD4 or CD8 cells, a large subset of thymocytes are positive forboth molecules
(1). Thesedouble-positive (DP) cells, which differentiate in the thymus to membrane
expression of TCR (2-4), have been the subject of much debate. The failure to ex-
pand such cells in vivo or in vitro was taken as evidence that they represent a "dead-
end" population (5, 6). However, recent evidence suggests that DP cells may be
precursors of mature SP lymphocytes (7-10).
We report here the establishment and characterization of DP clones from human
thymus. These cells show a stable DP phenotype, express a functional CD3TCR
complex, and give rise in vitro to SP variants.
Materials and Methods
Monoclonal Antibodies.
￿
The following mAbs were used: Leu 3a and Leu 3b (anti-CD4),
Leu 2a (anti-CD8), 55.2 (anti-CD2), Leu19, Leu 9 (anti-CD7), Leu 1 (anti-CD5) (Becton
Dickinson & Co., Mountain View, CA), OKT3 (anti-CD3, American Type Culture Collec-
tion [ATCC], Rockville, MA), 25.3 (anti-CDlla) and BL5 (anti-CD18) (Immunotech, Lu-
miny, France), Sl (antiTCR 6 chain), WT31 (which recognizes a CD3 epitope present on
a/(3 cells), BMA032 (antiTCRa//3), Nal/34, WM25, and IOC3 (anti-CDla,b,c). Anti-CD4
and anti-CD8 were direct labeled and the other mAbs were used unlabeled and detected
with FITC-conjugated goat anti-mouse Ig (Becton Dickinson & Co., Mountain View, CA).
Cloning of Thymic Cells.
￿
Thymic and peripheral blood samples were obtained from three
patients (1, 1, and 4 yr old) undergoing heart surgery. Thymus cell suspensions were purified
on Ficoll gradients and stored frozen in 10% DMSO. After thawing, living cells were recov-
ered through aPercoll cushion (1.078 density), washed twice, and doubly labeled with anti-
CD4 andanti-CD8 mAbs. Double-negative(DN), DP, CD4, andCD8 SP cellswere sorted
using a FACS440 sorter (Becton Dickinson & Co.). Cells were cloned by limiting dilution
in Terasaki plates (Nunc, Roskilde, Denmark) in 20 P1 RPMI 1640 medium (Gibco Labora-
tories, Grand Island, NY), supplemented with 5% human serum, 2 MM L-glutamine, 1%
nonessential aminoacids, 1 mM sodium pyruvate, 50 izg/ml Kanamycin (Gibco Laborato-
ries), in the presence of 1 l~g/ml PHA (Wellcome, Dartford, UK), 100 U/ml human rIL-2
(Hoffman-LaRoche, Nutley, NJ) and 5 x 105/ml 3,000 rad irradiated allogeneic PBMC as
feeders. After 10 d, positive wells were scored and cells were further restimulated and ex-
panded as above.
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Immunofluorescence.
￿
Cells were incubated for 30 min with mAbs at 4°C in PBS containing
0.01% azide and 0.5% BSA, and analyzed in a FACScan flow cytometer (Becton Dickinson
& Co.) with logarithmic amplification using FACScan software. Live gates were set by a com-
bination of low-angle forward and sideways light scatter. Markers were set against the plots
of control samples labeled with either anti-CD4 or anti-CD8 (in double fluorescence), or
second reagent alone (in single fluorescence).
mAbfacilitated Cytolysis.
￿
2 x 10; FcR' P815 mastocytoma cells labeled with "Cr were in-
cubated in 200 /Al RPMI/10% FCS with effector cells in the presence of 1 !rg/ml CKT3 or
BMA032 . Specific "Cr release was determined in a standard 4-h assay.
Results and Discussion
Establishment of Double-Positive Clones.
￿
Human thymocytes were doubly stained
with anti-CD4 and anti-CD8 mAbs, sorted, and cloned by limiting dilution. Clones
from all four populations (DP, CD4, or CD8 SP and DN) were established. In five
experiments and from three different thymuses, DP cells cloned with an efficiency
of 1-3%. The cloning efficiency of SP CD4 or CD8 cells was 10-30%, and that of
DN cellswas 0.5-8%. SP cells from peripheral blood of the same donors cloned with
an efficiency of 10-30%, which is also rather low, and is likely to be due to extensive
manipulation of the frozen cells. The poor cloning efficiency of DP cells could be
due either to intrinsic fragility or lower responsiveness to triggering stimuli (11). We
were, however, surprised to be able to clonethese populations, in view ofthe reported
failures to expand DP cells in vitro or in vivo in the mouse (5, 6), and of the fact
that human DP cells have been maintained in culture only for short periods (12).
All clones were analyzed for CD4, CD8, and TCR expression (Table I). 80°70 of
the clones from the sorted DP subset expressed both CD4 and CD8, while 20%
were SP. These could represent either DP cells which became SP in vitro, or a con-
taminating SP population, favored by the higher plating efficiency. All DP clones
carried TCR-a/0, since they were WT31' and bl - . Clones isolated from the SP-
sorted populations had an SP phenotype. Most of the clones derived from the DN
population had the expected CD4"8- phenotype and expressed TCR'Y/b. The rare
clones expressing an a/0 receptor were CD4 or CD8 SP.
All clones were positive for CD2, CD11a, and CD18 molecules. The range of rela-
TABLE I
Phenotypic Analysis of Clones Isolated from Thymus and Peripheral Blood
* Clones were obtained from three different thymuses and peripheral blood of
the same donors. Cells were stained with OKT3 (anti-CD3), WT31, and 61
mAbs for single-fluorescence analysis, and with anti-CD4 and anti-CD8 for
double-fluorescence analysis.
1 These three clones expressed low levels of CD4.
$ Three of these were CD4' and four CD8'.
Sorted
population Origin
Number of clones positive for:
CD4-CD8 CD4 CD8 CD3 WT31 61
CD4'8' Thymus 81 16 4 101 101 0
CD4'8 - Thymus 0 60 0 60 60 0
CD4-8' Thymus 31 0 65 68 66 2
C134-8- Thymus 0 3 11 68 7$ 61
Unsorted Peripheral
blood 0 57 32 90 89 1DE LIBERO AND LANZAVECCHIA
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tive amounts of these molecules, as well as ofCD3, CD4, CD8 was comparable in
DP and SP clones from both thymus and peripheral blood . All DP clones were also
CD7', Leu 19 + and CDla,b,c - . Remarkably, several DP clones were CD5 - or dull,
while the SP clones were always CD5 + . Since CD5 is acquired during T cell devel-
opment (1), and correlates with the acquisition of a mature phenotype (4), the ab-
sence ofthis marker suggests that DP clones represent a population that is not fully
differentiated (data not shown) .
Thus, the phenotype of DP clones differs from that of DP thymic cells ex vivo.
In the thymus, the DP population is heterogeneous, consisting ofTCR - , low and
high density TCR+, as well as CDl' and CDl - cells (13) . All clones express high
levels ofTCR molecules and are CDl - . This might reflect phenotypic changes due
to in vitro activation, or a selection exerted by cloning procedures . Therefore, these
clones may represent a subset of thymic DP cells .
Double-Positive Cells Can Switch to Single-Positive In Vitro.
￿
Some DP clones contain
a variable percentage (0.5-35%) of SP cells that is relatively stable for each clone
over time (Fig. 1) . Over a 10-mo period, the bulk of cellsremained DP and we never
observed a spontaneous shift towards an SP phenotype that involved all the cells .
Interestingly enough, some DP clones reproducibly generated CD4+ only, CD8+
only, or both types of SP cells. Similar findings have been reported in short-term
cultures of purified DP thymocytes (12), where, however, differential death of DP
and overgrowth of contaminating SP cells could not be ruled out . Our experiments
clearly demonstrate that this switch most likely occurs at the level of a single clone .
To ask whether this phenomenon is due to a modulation of CD4 or CD8, or to
irreversible differentiation, we sorted and expanded from several clones either bright
DP cells orSP variants . DP-sorted cells gave rise to the same pattern as the parental
clones (see an example in Fig . 2, a, b) . SP variants maintained a stable SP phenotype
(see Fig . 2, c, d), indicating that DP cells can irreversibly differentiate to SP in vitro .
It is worth noting that some CD4 SP variants still showed a very low expression
FIGURE 1 .
￿
Expression ofCD4 and CD8
on four representative clones established
fromDP thymocytes. (a, b) twoDP clones
that give rise to very few cells with both
CD4 andCD8 SP phenotype . (c, d) Clones
that give rise to more CD8' or CD4'
variants .306
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FIGURE 2 .
￿
CD4 and CD8 expression on
a DP clone and on its isolated variants .
(a) Parental clone ; (b) cells isolated from
the brightDP population; (c) cells isolated
from single CD8* variants ; (d) cells iso-
lated from single CD4' variants .
ofCD8 and we could not isolate variants that were totallyCD8- (see Fig . 2 d) . How-
ever, we could easily isolate CD8 + cells that completely lacked CD4.
The ability to lose independently CD4 or CD8 is peculiar of DP clones and is
not observed in peripheral blood- or thymus-derived SP clones .
Double-Positiae Cells Express a Functional 7LR-CD3 Complex.
￿
The TCR can trans-
duce a signal in DP clones since these cells are efficiently triggered to cytotoxicity
by both anti-CD3 and antiTCR mAbs (Table II) .
The presence of a functional CD3 complex suggests that the TCR can be used
by DP cells in their interactions with the thymic microenvironment . These findings
are in aggrement with evidence of calcium influx after CD3 triggering in human
CD4 +8+ thymocytes (14) and with data identifying the DP subset as target of toler-
ance induction (8-10) . Since thymic tolerance results from deletion of self-reactive
cells, it has been suggested that triggering ofTCR induces a suicide program in
DP thymocytes (15) . Our results demonstrate that this is not the general rule for
allDP cells, since our clones acquire effector function and proliferate in the presence
TABLE II
Double-Positive Clones Display a Functional TCR-CD3 Complex
' Specific 5 'Cr release of P815 target cells obtained in the presence of 1 Ftg of
BMA032 (anti-TCR-a/ß) and OKT3 (anti-CD3) mAbs .
mAbs :
Clone E/T ratio :
BMA032
20 :1 10 :1 5 :1 20 :1
OKT3
10 :1 5 :l
Medium
20 :1
Double-positive a/ß'
A31 56' 49 38 84 71 64 5
A54 75 66 49 76 75 67 3
A47 38 25 20 62 50 46 4
Double-negative .y/S'
A26 5 2 4 60 52 43 4DE LIBERO AND LANZAVECCHIA
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of anti-CD3 mAbs (data not shown). The possibilities exist that either (a) our cul-
ture conditions provide an accessory signal that bypasses tolerance induction, or
that (b) these DP clones represent a subset that is already partially differentiated
and therefore no longer tolerizable. More information will be obtained with the study
of the TCR repertoire of the DP clones and their SP variants.
Summary
Human thymocytes were sorted according to the expression of CD4 and CD8
molecules and clones representing the four subpopulations (DP, DN, and single CD4
or CD8 positive) were established. DP clones can be maintained for long periods
in tissue culture and give rise to a variable percentage of SP variants. These vari-
ants, when isolated and further expanded, do not revert to a DP phenotype. DP
clones express a functional TCR-CD3 complex, suggesting that this molecule can
interact with the thymic microenvironment during T cell differentiation.
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